Centerra Gold: Thompson Creek Could Deliver More Upside After A 71% Rally

Centerra is rated a cautious Buy, with estimated upside of 20–24%, as Thompson Creek production and higher molybdenum prices are expected to support future earnings. Thompson Creek’s heavy capex is largely complete, with production targeted to begin in mid-2027 and cash burn expected to decline. Molybdenum prices are nearly 70% above feasibility assumptions, materially increasing projected cash flow and overall NAV.

Analysis

The key valuation question is not whether spot molybdenum is above the feasibility case, but how much of that premium survives into realized prices and contracted volumes once Thompson Creek is producing. A spot-price uplift can raise modeled NAV quickly while cash flow remains deferred; investors may therefore be paying today for a commodity spread and execution several years ahead. Higher prices could also prompt supply response or substitution in steel-alloy demand, limiting the durability of the uplift.

The near-term setup is more catalyst-driven than earnings-driven: any capex confirmation or construction milestone can reduce perceived funding and schedule risk, while cost overruns or slippage would reintroduce a longer cash-burn period. The 1–3 month test is whether updated company disclosures support the analyst’s price and cash-flow assumptions. Over 6–18 months, commissioning readiness and the molybdenum price curve matter more than today’s spot quote. The contrarian risk is that the market may capitalize an unusually strong price environment too generously; conversely, if investors still treat Thompson Creek primarily as a funding burden, credible milestones could improve the risk premium. No valuation inputs or independent project update are provided, so the stated upside is not independently verifiable.

Key Decisions for Investors

• Treat Centerra as a conditional project-and-commodity exposure, not a near-term earnings acceleration trade; avoid sizing the thesis on spot molybdenum alone.
• Before adding, verify the latest Thompson Creek capex-to-complete, contingency, funding plan, production ramp assumptions, and realized-price exposure. Reassess if disclosures show higher remaining spend or a schedule shift.
• Track the forward molybdenum curve and evidence of supply response. A sustained retreat toward feasibility assumptions would weaken the NAV case even if construction proceeds on schedule.
• Potential entry catalyst: documented construction milestones and capex tracking that reduce execution risk. Falsify the thesis on material cost escalation, delayed startup, or guidance that indicates materially lower production or cash flow than the analyst case.
• There is not enough information here to support a relative-value pair or options trade; monitor for a valuation dislocation after project updates rather than forcing a position.